Abiopharma

🔍 ENRIGHT PATRICK G (Executive)

Company: Vera Therapeutics, Inc. (VERA)

Report Date: 2025-12-11

Detailed Transactions and Holdings:

• Acquired 5,882 shares of Class A Common Stock at $42.5 per share (Direct)
  Date: 2025-12-11 | Code: P | equity_swap_involved: false | shares_owned_after: 5,882.00 | transaction_form_type: 4
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2025-12-11 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 1,797,619.00 | Footnotes: F1
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2025-12-11 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 3,596,593.00 | Footnotes: F2

Footnotes:

• F1: These shares are held by Longitude Prime Fund, L.P. ("LPF"). Longitude Prime Partners, LLC ("LPP") is the general partner of LPF and may be deemed to have voting and dispositive power over the securities held by LPF. The Reporting Person and Juliet Tammenoms Bakker are the managing members of LPP and may be deemed to share voting and dispositive power over the shares held by LPF. Each of LPP, the Reporting Person and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
• F2: These shares are held by Longitude Venture Partners IV, L.P ("LVPIV"). Longitude Capital Partners IV, LLC ("LCPIV") is the general partner of LVPIV and may be deemed to have voting and dispositive power over the shares held by LVPIV. The Reporting Person and Ms. Tammenoms Bakker are managing members of LCPIV and may be deemed to share voting and dispositive power with respect to the shares held by LVPIV. Each of LCPIV, the Reporting Person and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.